» Articles » PMID: 36582169

Quantifying Leg Muscle Deoxygenation During Incremental Cycling in Hypoxemic Patients with Fibrotic Interstitial Lung Disease

Overview
Date 2022 Dec 30
PMID 36582169
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hypoxaemia and cardiocirculatory abnormalities may impair muscle oxygen (O ) delivery relative to O requirements thereby increasing the rate of O extraction during incremental exercise in fibrotic interstitial lung disease (f-ILD). Using changes in deoxyhaemoglobin concentration ([HHb]) by near-infrared spectroscopy (NIRS) as a proxy of O extraction, we investigated whether a simplified (double-linear) approach, previously tested in heart failure, would provide useful estimates of muscle deoxygenation in f-ILD.

Methods: A total of 25 patients (23 men, 72 ± 8 years; 20 with idiopathic pulmonary fibrosis, lung diffusing capacity for carbon monoxide = 44 ± 11% predicted) and 12 age- and sex-matched healthy controls performed incremental cycling to symptom limitation. Changes in vastus lateralis [HHb] assessed by NIRS were analysed in relation to work rate (WR) and O uptake throughout the exercise.

Results: Patients showed lower exercise capacity than controls (e.g., peak WR = 67 ± 18% vs. 105 ± 20% predicted, respectively; p < 0.001). The [HHb] response profile was typically S-shaped, presenting three distinct phases. Exacerbated muscle deoxygenation in patients versus controls was evidenced by: (i) a steeper mid-exercise [HHb]-WR slope (0.30 ± 0.22 vs. 0.11 ± 0.08 μmol/W; p = 0.008) (Phase 2), and (ii) a larger late-exercise increase in [HHb] (p = 0.002) (Phase 3). Steeper [HHb]-WR slope was associated with lower peak WR (r = -0.70) and greater leg discomfort (r = 0.77; p < 0.001) in f-ILD.

Conclusion: This practical approach to interpreting [HHb] during incremental exercise might prove useful to determine the severity of muscle deoxygenation and the potential effects of interventions thereof in hypoxemic patients with f-ILD.

Citing Articles

ERS International Congress 2023: highlights from the Respiratory Clinical Care and Physiology Assembly.

Gonsard A, Mekov E, Barron S, Castellana G, Khurtsidze E, Vontetsianos A ERJ Open Res. 2024; 10(3).

PMID: 38770003 PMC: 11103686. DOI: 10.1183/23120541.00178-2024.


Systemic Determinants of Exercise Intolerance in Patients With Fibrotic Interstitial Lung Disease and Severely Impaired D.

Smyth R, James M, Vincent S, Milne K, Marillier M, Domnik N Respir Care. 2023; 68(12):1662-1674.

PMID: 37643871 PMC: 10676244. DOI: 10.4187/respcare.11147.


The relationship between perceived and performance fatigability in severe fibrotic interstitial lung disease: a prospective, cross-sectional study.

Marillier M, Gruet M, Bernard A, Verges S, Moran-Mendoza O, Neder J ERJ Open Res. 2023; 9(3).

PMID: 37228269 PMC: 10204817. DOI: 10.1183/23120541.00726-2022.